https://www.indianpharmapost.com/us-fda-clears-innocares-clinical-trial-of-pan-trk-inhibitor-icp-723-101302021-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/us-fda-grants-lantern-pharma-additional-orphan-drug-tag-for-lp-184-101312021-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-to-commercialise-winlevi-in-the-us-and-canada-101322021-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofis-dupixent-pivotal-trial-meets-all-primary-and-secondary-endpoints-for-treatment-of-atopic-dermatitis-101332021-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-announce-launch-two-drugs-in-the-us-market-101342021-08-31T00:00:00+05:30always0.9